|
¾ÆÀÌÄÜŬ¸®´ÏÄø®¼Ä¡ |
Global CRO ICON Korea CRA II / Sr. Contract & Grant Anal
¼¿ï °³²±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
CRA/ÀÓ»óPM/CRM |
2³â¡è |
ä¿ë½Ã |
03.11 |
|
|
ICON Clinical Research Korea |
Study Start-up Associate
¼¿ï °³²±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
CRA/ÀÓ»óPM/CRM |
2³â¡è |
ä¿ë½Ã |
04.22 |
|
|
¾ÆÇÁ·Î¸Þµð¿Â |
¾ÆÇÁ·Î¸Þµð¿Â ±¹³» º´¿ø¿µ¾÷ÆÀ(¼¿ï/°æ±â) + ¸¶ÄÉÆÃÆÀ
¼¿ï ÀüÁö¿ª | ´ëÇÐ(2~3³â) Á¹¾÷ |
Á¦¾à¿µ¾÷/ÀÇ·á±â¿µ¾÷ |
°æ·Â¹«°ü |
ä¿ë½Ã |
05.17 |
|
|
(ÁÖ)ÄھƽºÆ®·Ð |
ÀÇ·á±â±â A/S ¿£Áö´Ï¾î ¸ðÁý
¼¿ï °³²±¸ | °íµîÇб³ |
AS/Á¤ºñ/¼ö¸®/¼³Ä¡ |
°æ·Â¹«°ü |
ä¿ë½Ã |
05.14 |
|
|
¾ÆÇÁ·Î¸Þµð¿Â |
¸ÞµðÄÿµ¾÷ÆÀ ¸ðÁý[¼¿ï/°æ±â ¼öµµ±Ç]
¼¿ï ÀüÁö¿ª, °æ±â ÀüÁö¿ª | ´ëÇÐ(2~3³â) Á¹¾÷ |
Á¦¾à¿µ¾÷/ÀÇ·á±â¿µ¾÷ |
°æ·Â¹«°ü |
ä¿ë½Ã |
04.09 |
|
|
(ÁÖ)¿¥¿¡ÀÌ¿¡½º |
(ÁÖ)¿¥¿¡ÀÌ¿¡½º - ±¹³» ¿µ¾÷»ç¿ø ¸ðÁýÇÕ´Ï´Ù.
¼¿ï °³²±¸ | Çз¹«°ü |
Á¦¾à¿µ¾÷/ÀÇ·á±â¿µ¾÷ |
½ÅÀÔ |
ä¿ë½Ã |
09.15 |
|
|
°³²Â÷º´¿ø |
°³²Â÷º´¿ø ¾ß°£¾à»ç Ãʺù ¾È³»
¼¿ï °³²±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
¾à»ç/ÇѾà»ç |
1³â¡è |
ä¿ë½Ã |
05.11 |
|
|
´ëȱâ±â(ÁÖ) |
ÀÇ·á±â±â ±¹³»¿µ¾÷ÆÀ ±¹³»¿µ¾÷ Á¤±ÔÁ÷ ä¿ë
¼¿ï °³²±¸ | °íµîÇб³ |
Á¦¾à¿µ¾÷/ÀÇ·á±â¿µ¾÷ |
°æ·Â¹«°ü |
ä¿ë½Ã |
05.02 |
|
|
´ëȱâ±â(ÁÖ) |
ÀÇ·á±â±â ±¹³»¿µ¾÷ÆÀ ±¹³»¿µ¾÷ Á¤±ÔÁ÷ ä¿ë
¼¿ï °³²±¸ | °íµîÇб³ |
Á¦¾à¿µ¾÷/ÀÇ·á±â¿µ¾÷ |
°æ·Â¹«°ü |
ä¿ë½Ã |
05.26 |
|
|
(ÁÖ)Ŭ·¡½Ã½º |
±³À°°³¹ßÆÀ °æ·ÂÁ÷ ä¿ë
¼¿ï °³²±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
Çмú/±³À°/»ó´ã |
6³â¡è |
ä¿ë½Ã |
04.16 |
|
|
¾ÆÀÌÄÜŬ¸®´ÏÄø®¼Ä¡ |
Entry level Clinical Research Associate (CRA) ä¿ë
¼¿ï °³²±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
CRA/ÀÓ»óPM/CRM |
°æ·Â¹«°ü |
ä¿ë½Ã |
11.05 |
|
|
BD KOREA |
Clinical Specialist (°£È£»ç)
¼¿ï ÀüÁö¿ª | Çз¹«°ü |
°£È£»ç |
3³â¡è |
ä¿ë½Ã |
04.05 |
|
|
BD KOREA |
Sales Representative (Diagnostic Systems)
¼¿ï °³²±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
Á¦¾à¿µ¾÷/ÀÇ·á±â¿µ¾÷ |
3³â¡è |
ä¿ë½Ã |
03.08 |
|
|
BD KOREA |
Marketing Specialist(PreAnalytical Systems)
¼¿ï °³²±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
¸¶ÄÉÆÃ/±âȹ/±³À° |
3³â¡è |
ä¿ë½Ã |
03.08 |
|
|
BD KOREA |
Customer Quality Specialist
¼¿ï °³²±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
Ç°Áú°ü¸®/Ç°Áúº¸Áõ |
3³â¡è |
ä¿ë½Ã |
03.08 |
|